Bafna Pharmaceuticals Limited (NSE:BAFNAPH)
India · Delayed Price · Currency is INR 242.45
+4.75 (2.00%)
Aug 21, 2026, 3:14 PM IST
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 5.74 billion as of August 21, 2026. Its market cap has increased by 133.84% in one year.
Market Cap
5.74B
Enterprise Value
6.09B
Revenue
1.43B
Ranking
n/a
PE Ratio
74.74
Stock Price
242.45
ChartMarket Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 5.74B, an increase of 52,606.51%. That is a compound annual growth rate of 163.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 5.74B | 60.86% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 23.50B |
| Indoco Remedies | 20.89B |
| Windlas Biotech | 20.50B |
| Sakar Healthcare | 20.31B |
| Jagsonpal Pharmaceuticals | 15.59B |
| Sigachi Industries | 11.48B |
| Amanta Healthcare | 6.72B |
| Valiant Laboratories | 5.20B |